TICS: Telehealth Interventions for Cardiac Surgery

Sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05621954
Collaborator
Liverpool Centre for Cardiovascular Science (Other)
448
1
2
11
40.8

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare telehealth monitoring at home against usual care in patients undergoing planned heart surgery. The main questions it aims to answer are:

  1. Can telehealth improve quality of life prior to surgery

  2. Can telehealth prevent serious deterioration requiring hospital or primary care attendance

Participants awaiting heart surgery will be randomly allocated to either telehealth remote monitoring of symptoms, blood pressure, heart rate, oxygen levels and activity levels or they will be allocated to usual care which is unmonitored on the waiting list for surgery.

Researchers will compare telehealth to usual care to see if it improves quality of life or prevents deteriorations on the waiting list.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Telehealth Monitoring
N/A

Detailed Description

Patients on elective cardiac surgery waiting lists can deteriorate, presenting via acute services as urgent inpatients as a result of their decompensation and facing increased surgical risk. With increases in waiting times prevalent through the country, and healthcare resources under pressure from Covid-related backlogs, it is imperative to find ways to monitor and escalate the most vulnerable patients and to provide safe methods of providing healthcare interventions outside conventional hospital settings. Remote monitoring identifies patients at need, and allows tertiary-care led interventions to prevent deterioration in the first instance. Such facilities could also enhance recovery following treatment and reduce the risks of complications and readmissions post-operatively.

The benefits and risks of such programmes is, however, not well understood: additional monitoring may increase the burden of responsibility on patients or monitoring facilities without providing additional safeguards to the patient. The advantages of early detection may not translate into improved outcomes and the onus on the patient to report in may reduce quality of life rather than enhance it.

The researchers therefore seek to identify if telehealth monitoring can improve health related quality of life, reduce unplanned admissions and healthcare resource utilisation and enhance pre-habilitation using protocolised patient engagement facilities to reduce complications and improve risk-stratification metrics such as smoking status, diabetic control and BMI.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
448 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Pragmatic, single-centre, individual patient, randomized controlled trialPragmatic, single-centre, individual patient, randomized controlled trial
Masking:
None (Open Label)
Masking Description:
No masking
Primary Purpose:
Supportive Care
Official Title:
Telehealth for Pre- and Post-Operative Monitoring of Cardiac Surgery Patients - A Randomised Controlled Trial
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telehealth monitoring

Telehealth remote monitoring provided by a specialised service with a monitoring and patient education app featuring: Symptom, blood pressure, weight, heart rate and oxygen saturation monitoring with optional step counters Customised algorithms with patient feedback for prehabilitation (e.g. patient self-reporting of symptoms, activities and health-related activities with positive feedback loops and recommendations for self-directed management) Centralised weekly review and escalation to expedited surgery if deteriorations noted Post-operative monitoring with symptom, blood pressure, weight, heart rate, oxygen saturation and photographic wound review with optional step counters

Procedure: Telehealth Monitoring
Connected devices and smartphone apps to measure symptoms and observations at home, with centralisation of results to a staffed hub
Other Names:
  • Docobo
  • Remote Monitoring
  • Doc@Home
  • No Intervention: Standard of Care

    Standard of care will be no remote monitoring for patients whilst on the waiting list or after discharge from hospital. Access to tertiary services for advice, information or to report deteriorations will be through conventional existing modes such as printed or online literature provided at the time of outpatient review, telephone access to administrative staff allowing clinical information to be conveyed to the usual care team, and local primary care and emergency services for acute deteriorations. Existing standard of care remote services (e.g. wound monitoring by digital photograph reviews) will continue.

    Outcome Measures

    Primary Outcome Measures

    1. Change from baseline to admission in Healthcare related Quality of Life Change (EQ5D5L) [From baseline to admission for surgery (up to 52 weeks)]

      EQ5D5L will be measured by electronic questionnaire by the patient or a researcher on their behalf and indexed for representation on a scale from 0 (worst health, equivalent to being dead) - 1 (best health). The difference in measures between baseline (randomisation) and admission for surgery (up to 52 weeks) will be measured.

    2. Healthcare resource use during waiting list (composite counts of admission to hospital, A&E attendance and primary care appointment utilisation) [From baseline (randomisation) to admission for surgery (up to 52 weeks)]

      Composite counts of admissions to hospital, Accident & Emergency hospital attendance, and primary care appointments for this health condition or complications of this health condition adjudicated by the research team. The counts will be accrued from baseline (randomisation) to admission for surgery (up to 52 weeks).

    Secondary Outcome Measures

    1. Unplanned admissions pre- and post-surgery [From baseline to discharge from outpatient cardiac surgery service (up to 52 weeks)]

      Rates of unplanned admissions to hospital both pre- and post- surgery

    2. Diabetes control [From baseline (randomisation) to admission for surgery (up to 52 weeks)]

      Change from baseline to admission on HbA1c

    3. Smoking cessation [From baseline (randomisation) to admission for surgery (up to 52 weeks)]

      Change from baseline to admission on HbA1c

    4. Post-operative Quality of Life Measures [From discharge from hospital admission to discharge from outpatient cardiac surgery service (up to 52 weeks)]

      Healthcare related Quality of Life Change (EQ5D5L change) as an indexed measure from 0 (worst health, equivalent to being dead) to 1 (best health).

    5. Change in post-operative complications [From discharge from hospital admission to discharge from outpatient cardiac surgery service (up to 52 weeks)]

      Rates of post-operative complications including mortality, stroke, lower respiratory tract infections, surgical site infections

    6. Length of hospital stay [From admission for surgery to discharge from hospital (up to 52 weeks)]

      Total in-hospital stay

    7. Ventilator Time [From admission for surgery to discharge from hospital (up to 52 weeks)]

      Total cumulative time with invasive ventilation following index procedure

    8. Length of intensive care stay [From admission for surgery to discharge from hospital (up to 52 weeks)]

      Total critical care stay for index admission

    9. Weight loss [From baseline (randomisation) to admission for surgery (up to 52 weeks)]

      Change in body mass index on waiting list

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Adult patients over 18y referred and accepted for cardiac surgery

    2. Able to consent to participate

    Exclusion Criteria:
    1. Urgent or emergent surgery

    2. Surgery planned within 3 weeks of first cardiac surgery outpatient review

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Liverpool Heart and Chest Hospital Liverpool Mersey United Kingdom L14 3PE

    Sponsors and Collaborators

    • Liverpool Heart and Chest Hospital NHS Foundation Trust
    • Liverpool Centre for Cardiovascular Science

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Liverpool Heart and Chest Hospital NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT05621954
    Other Study ID Numbers:
    • TICS
    First Posted:
    Nov 18, 2022
    Last Update Posted:
    Nov 18, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Liverpool Heart and Chest Hospital NHS Foundation Trust
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 18, 2022